IAM
INDP icon

Ion Asset Management’s Indaptus Therapeutics INDP Stock Holding History

Ion Asset Management’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4
Closed -$56K – 24
2015
Q3 		$56K Buy
+4
New +$52.5K 0.08% 23

Other funds holding INDP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ion Asset Management's INDP Position: Q4 2015 in Review

Ion Asset Management sold out of Indaptus Therapeutics (INDP) in Q4 2015, closing a stake of 4 shares — an estimated $56K sold.

Ion Asset Management first reported a position in INDP in Q3 2015 and held it in 1 quarter. The position peaked at $56K in Q3 2015. 6 funds tracked by Wall St. Rank hold INDP as of Q4 2015.

  • Ion Asset Management reported no remaining Indaptus Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Ion Asset Management sold 4 Indaptus Therapeutics shares in Q4 2015, an estimated $56K.
  • Ion Asset Management first reported a position in Indaptus Therapeutics in Q3 2015 and held it in 1 quarter.
  • Ion Asset Management's Indaptus Therapeutics position peaked at $56K in Q3 2015.
  • 6 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q4 2015.

Based on Ion Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.